Severalapproved therapeutic products, which are currently available as intravenousdosage forms, are being reformulated and evaluated for subcutaneous administration.Further, many existing drug delivery devices, including prefilled syringes, peninjectors, auto injectors, needle-free injectors and large volume wearableinjectors, have been / are being designed for subcutaneous administration ofbiologics.
The USD 180+ billion (by2030) financial opportunity associated with subcutaneous biologics, affiliateddrug delivery systems and subcutaneous formulation technology licensing deals,has been analyzed across the following segments:
Subcutaneous Biologic Drugs andAffiliated Technologies Market, Trends by 2030
MarketSegment:
Phaseof development
· Approved
· Pre-registration & Phase III
· Phase II & Phase II/III
Typeof molecule
· Cell and gene therapies
· Monoclonal antibodies
· Proteins
· Peptides (recombinant)
· Vaccines
· Others
Targettherapeutic area
· Autoimmune disorders
· Blood disorders
· Bone disorders
· Genetic disorders
· Metabolic disorders
· Neurological disorders
· Oncological disorders
· Respiratory disorders
· Others
Typeof drug delivery system
· Large volume wearable injectors
· Autoinjectors
· Prefilled syringes
· Needle-free injectors
· Drug reconstitution systems
· Revenues from licensing deals
· Upfront payments
· Milestone payments
Keygeographical regions
· North America
· Europe
· Asia Pacific
· Rest of the World
Requestfor PDF Sample: https://www.rootsanalysis.com/reports/314/request-sample.html
The Subcutaneous Biologics, Technologies and DrugDelivery Systems (3rd Edition), 2020-2030 report features the followingcompanies, which we identified to be key players in this domain:
MarketKey Players:
· Adocia
· Ajinomoto Bio-Pharma Services
· Arecor
· Alteogen
· Ascendis Pharma
· Avadel Pharmaceuticals
· Camurus
· Creative BioMart
· Creative Biolabs
· DURECT
· Eagle Pharmaceuticals
· Halozyme Therapeutics
· MedinCell
· Xeris Pharmaceuticals
· Serina Therapeutics
Requestfor PDF Sample: https://www.rootsanalysis.com/reports/314/request-sample.html
Tableof Contents
1. Preface
2. ExecutiveSummary
3. Introduction
4. SubcutaneousBiologics: Current Market Landscape
5. Case Study:Leading Subcutaneous Biologics
6. SubcutaneousFormulation Technologies: Current Market Landscape
7. SubcutaneousFormulation Technology Developers: Company Competitiveness Analysis
8. SubcutaneousFormulation Technology Developers: Company Profiles
9. Partnershipsand Collaborations
10. SubcutaneousDrug Delivery Systems: Current Market Landscape
11. SwotAnalysis
12. MarketForecast and Opportunity Analysis
13. ConcludingRemarks
14. ExecutiveInsights
15. Appendix1: Tabulated Data
16. Appendix 2:List Of Companies And Organization
RequestFor Customization: https://www.rootsanalysis.com/reports/314/request-customization.html
AboutRoots Analysis
RootsAnalysis is one of the fastest growing marketresearch companies, sharing fresh and independent perspectives in thebio-pharmaceutical industry. The in-depth research, analysis and insights aredriven by an experienced leadership team which has gained many years ofsignificant experience in this sector. If you’d like help with your growingbusiness needs, get in touch at info@rootsanalysis.com
ContactInformation
RootsAnalysis Private Limited
GauravChaudhary
+1(415) 800 3415
